Publications of Pawel Zmora

Kupke, S. Y.; Riedel, D.; Frensing, T.; Zmora, P.; Reichl, U.: A Novel Type of Influenza A Virus-Derived Defective Interfering Particle with Nucleotide Substitutions in Its Genome. Journal of Virology 93 (4), 01786-18 (2019)

Rüdiger, D.; Kupke, S. Y.; Laske, T.; Zmora, P.; Reichl, U.: Multiscale modeling of influenza A virus replication in cell cultures predicts infection dynamics for highly different infection conditions. PLoS Computational Biology 15 (2), e1006819 (2019)

Kupke, S. Y.; Riedel, D.; Frensing, T.; Zmora, P.; Reichl, U.: Single-cell analysis uncovers a novel influenza A virus-derived defective interfering particle for antiviral therapy. In Vaccine Technology VII, 133. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)

Rüdiger, D.; Kupke, S. Y.; Zmora, P.; Reichl, U.: Multiscale model of influenza virus infection predicts viral release dynamics in cell cultures for a wide range of infection conditions. 3rd Workshop on Virus Dynamics, Heidelberg, Germany (2017)

Zmora, P.: Vaccines against emerging infectious diseases (Ebola, SARS, MERS, influenza) - future or present? Tropical & Parasitic Disease Conference, Poznan, Poland (2017)

Zmora, P.; Moldenhauer, A. S.; Erdelt, S.; Dahlmann, F.; Sewald, K.; Zhao, Y.; Bruns, S.; Poehlmann, S.: Nafamostat is a new potent inhibitor of trypsin-independent influenza A viruses spread. 27^th Annual Meeting of the Society for Virology, Marburg, Germany (2017)

Kupke, S. Y.; Frensing, T.; Zmora, P.; Reichl, U.: Protective Interfering Nucleic Acid Molecule And Virus - Like Particle, Virsl Vector, or Virus Particle Containing the same as well as Pharmaceutical Composition Containing the Protective Interfering Nucleic Acid and its use. US 2020/0392504A1 (2020)